Assignee
ACCESS TO ADVANCED HEALTH INST
US·17 granted patents·13 pending applications·3 citations·filing 2013–2025
Top patents by PatentIndex Score
30 records- 0187US12344641B2Immunogenic compositions comprising Mycobacterium tuberculosis polypeptides and fusions thereofACCESS TO ADVANCED HEALTH INST·Filed 2024·Granted Jul 1, 2025·0 cites·15 claims
- 0282US12337065B2Compositions for treating viral infections and methods for sameACCESS TO ADVANCED HEALTH INST·Filed 2022·Granted Jun 24, 2025·0 cites·20 claims
- 0382US11369672B2Compositions and methods for treating an active Mycobacterium tuberculosis infectionACCESS TO ADVANCED HEALTH INST·Filed 2018·Granted Jun 28, 2022·1 cites·25 claims
- 0481US11801223B2Single vial vaccine formulationsACCESS TO ADVANCED HEALTH INST·Filed 2014·Granted Oct 31, 2023·2 cites·44 claims
- 0581US2025241854A1Nanostructured lipid carriers and stable emulsions and uses thereofACCESS TO ADVANCED HEALTH INST·Filed 2024·Application pending·0 cites
- 0677US12491161B2Single vial vaccine formulationsACCESS TO ADVANCED HEALTH INST·Filed 2023·Granted Dec 9, 2025·0 cites·17 claims
- 0776US12491243B2Formulation containing TLR agonist and methods of useACCESS TO ADVANCED HEALTH INST·Filed 2022·Granted Dec 9, 2025·0 cites·12 claims
- 0876US12440559B2Formulation containing TLR agonist and methods of useACCESS TO ADVANCED HEALTH INST·Filed 2022·Granted Oct 14, 2025·0 cites·10 claims
- 0976US11897922B2Immunogenic compositions comprising Mycobacterium tuberculosis polypeptides and fusions thereofACCESS TO ADVANCED HEALTH INST·Filed 2021·Granted Feb 13, 2024·0 cites·12 claims
- 1075US2025304629A1Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereofACCESS TO ADVANCED HEALTH INST·Filed 2025·Application pending·0 cites
- 1174US11376325B2Method of inducing an immune response using an expression construct and GLAACCESS TO ADVANCED HEALTH INST·Filed 2020·Granted Jul 5, 2022·0 cites·9 claims
- 1274US2025242016A1Formulation containing tlr agonist and methods of useACCESS TO ADVANCED HEALTH INST·Filed 2025·Application pending·0 cites
- 1373US12201722B2Nanostructured lipid carriers and stable emulsions and uses thereofACCESS TO ADVANCED HEALTH INST·Filed 2021·Granted Jan 21, 2025·0 cites·49 claims
- 1472US12427116B2Nanoalum particles containing a pegylated lipid sizing agentACCESS TO ADVANCED HEALTH INST·Filed 2021·Granted Sep 30, 2025·0 cites·23 claims
- 1572US12318484B2Pegylated liposomes and methods of useACCESS TO ADVANCED HEALTH INST·Filed 2021·Granted Jun 3, 2025·0 cites·18 claims
- 1672US2023381292A1Vaccines Comprising Mycobacterium Leprae Polypeptides for the Prevention, Treatment, and Diagnosis of LeprosyACCESS TO ADVANCED HEALTH INST·Filed 2023·Application pending·0 cites
- 1771US12285483B2Solanesol vaccine adjuvants and methods of preparing sameACCESS TO ADVANCED HEALTH INST·Filed 2021·Granted Apr 29, 2025·0 cites·23 claims
- 1870US2023116042A1Adjuvant formulations comprising tlr4 agonists and methods of using the sameACCESS TO ADVANCED HEALTH INST·Filed 2022·Application pending·0 cites
- 1966US11801290B2Vaccines comprising Mycobacterium leprae polypeptides for the prevention, treatment, and diagnosis of leprosyACCESS TO ADVANCED HEALTH INST·Filed 2017·Granted Oct 31, 2023·0 cites·24 claims
- 2063US11510875B2Adjuvant formulations comprising TLR4 agonists and methods of using the sameACCESS TO ADVANCED HEALTH INST·Filed 2013·Granted Nov 29, 2022·0 cites·61 claims
- 2163US2025241857A1Pegylated liposomes and methods of useACCESS TO ADVANCED HEALTH INST·Filed 2025·Application pending·0 cites
- 2263US2025295591A1Single vial vaccine formulationsACCESS TO ADVANCED HEALTH INST·Filed 2025·Application pending·0 cites
- 2362US2025186581A1Solanesol vaccine adjuvants and methods of preparing sameACCESS TO ADVANCED HEALTH INST·Filed 2025·Application pending·0 cites
- 2461US2025241864A1Nanoalum particles containing a pegylated lipid sizing agentACCESS TO ADVANCED HEALTH INST·Filed 2025·Application pending·0 cites
- 2559US11344619B2Formulation containing TLR agonist and methods of useACCESS TO ADVANCED HEALTH INST·Filed 2017·Granted May 31, 2022·0 cites·17 claims
- 2657US2023310569A1Genetically-adjuvanted rna vaccinesACCESS TO ADVANCED HEALTH INST·Filed 2021·Application pending·0 cites
- 2754US2023338501A1Live-attenuated rna hybrid vaccine technologyACCESS TO ADVANCED HEALTH INST·Filed 2021·Application pending·0 cites
- 2853US2023287038A1Purified saponins and chromatographic process for purification of sameACCESS TO ADVANCED HEALTH INST·Filed 2021·Application pending·0 cites
- 2953US2023310323A1Co-lyophilized rna and nanostructured lipid carrierACCESS TO ADVANCED HEALTH INST·Filed 2021·Application pending·0 cites
- 3050US12318436B2Composition and method for spray drying an adjuvant vaccine emulsionACCESS TO ADVANCED HEALTH INST·Filed 2020·Granted Jun 3, 2025·0 cites·36 claims
Join the waitlist — get patent alerts
Get an alert when ACCESS TO ADVANCED HEALTH INST files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →